Time course of zinc deprivation-induced alterations of mice behavior in the forced swim test
Tóm tắt
Zinc is an important trace element essential for numerous bodily functions. It is believed that a deficiency of zinc can lead to various conditions, including depression, on which this study is focused. It is still not known if hypozincemia leads to the development of depression or whether zinc deficiency is a result of depression. It is hypothesized that zinc may be a therapeutic agent or supplement that would help to reverse the symptoms of this disease. In the present study, the behavior of mice was assessed 2,4, and 10 weeks following administration of a zinc deficient diet. To evaluate animal activity we used the forced swim test (FST). After 2-week zinc deprivation we demonstrated a significant reduction in the immobility time. However, after 4 and 10 weeks of zinc deprivation the mice exhibited an increased immobility time. There were no changes in locomotor activity at each time period. After 2-, 4- and 10-week zinc deprivation and the subsequent FST, serum zinc concentration was decreased and determined to be 59, 61 and 20%, respectively, compared with appropriate controls. The serum corticosterone concentration in mice after 2-, 4-and 10-week zinc deprivation and subjected to the FST was also assessed, whereby the differences between the control and experimental animals were demonstrated (increased by: 11, 97 and 225%, respectively). The obtained results indicate that zinc deprivation induced “pro-depressive” behavior (after the initial period of “anti-depressive” behavior). This pro-depressive behavior correlates with enhanced serum corticosterone concentration.
Tài liệu tham khảo
Bao AM, Meynen G, Swaab DF: The stress system in depression and neurodegeneration: Focus on the human hypothalamus. Brain Res Rev, 2008, 57, 531–553.
Brown KH, Wuehler SE, Peerson JM: The importance of zinc human nutrition and estimation of the global prevalence of zinc deficiency. Food Nutr Bull, 2001, 22, 113–125.
Burcusa SL, Iacono WG: Risk for recurrence in depression. Clin Psychol Rev, 2007, 27, 959–985.
Chu Y, Mouat MF, Harris RBS, Coffield JA, Grider A: Water maze performance and changes in serum corticos-terone levels in zinc-deprived and pair-fed rats. Physiol Behav, 2003, 78, 569–578.
Cieślik K, Klenk-Majewska B, Danilczuk Z, Wróbel A, Łupina T, Ossowska G: Influence of zinc suplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats. Pharmacol Rep, 2007, 59, 46–52.
Cieślik K, Sowa-Kućma M, Ossowska G, Legutko B, Wolak M, Opoka W, Nowak G: Chronic unpredictable stress-induced reduction in the hippocampal brain-derived neurotrophic factor (BDNF) gene expression is antagonized by zinc treatment. Pharmacol Rep, 2011, 63, 537–543.
Cope EC, Levenson CW: Role of zinc in the development and treatment of mood disoerders. Curr Opin Clin Nutr Metab Care, 2010, 13, 685–689.
Cunha MP, Machado DG, Bettio LEB, Capra JC, Rodrigues ALS: Interaction of zinc with antidepressants in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry, 2008, 32, 1913–1920.
El Hendy HA, Yousef MI, Abo El-Naga NI: Effect of dietary zinc deficiency on hematological and biochemical parameters and concentrations of zinc, copper, and iron in growing rats. Toxicology, 2001, 167, 163–170.
Halsted JA, Ronaghy HA, Abadi P: Zinc deficiency in man. Am J Med, 1972, 53, 277–284.
Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry, 1994, 51, 8–19.
Kroczka B, Brański P, Palucha A, Pilc A, Nowak G: Antidepressant-like properties of zinc in rodent forced swim test. Brain Res Bull, 2001, 55, 297–300.
Kroczka B, Zięba A, Dudek D, Pilc A, Nowak G: Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. Pol J Pharmacol, 2000, 52, 403–406.
Levenson CW: Zinc regulation of food intake: new insights on the role of neuropeptide. Y Nutr Rev, 2003, 61, 247–249.
Levenson CW: Zinc: the new antidepressant? Nutr Rev, 2006, 64, 39–42.
Maes M, D’Haese PC, Scharpe S, D’Hondt P, Cosyns P, De Broe ME: Hypozincemia in depression. J Affect Disord, 1994, 31, 135–140.
Maes M, De Vos N, Demedts P, Wauters A, Neels H: Lower serum zinc in major depression in relation to changes in serum acute phase proteins. J Affect Disord, 1999, 56, 189–194.
Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, Altamura C, Desnyder R: Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry, 1997, 42, 349–358.
McLoughlin IJ, Hodge SJ: Zinc in depressive disorder. Acta Psychiatr Scand, 1990, 82, 451–453.
Młyniec K, Nowak G: Zinc deficiency induces depression-like behavior in the tail suspension test in mice. Pharmacol Rep, 2012, 64, in press.
Nakashima AS, Dyck RH: Zinc and cortical plasticity. Brain Res Rev, 2009, 59, 347–373.
Nowak G, Siwek M, Dudek D, Zięba A, Pilc A: Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol, 2003, 55, 1143–1147.
Nowak G, Szewczyk B, Pilc A: Zinc and depression. An update. Pharmacol Rep, 2005, 57, 713–718.
Nowak G, Szewczyk B, Wierońska JM, Brański P, Palucha A, Pilc A, Sadlik K, Piekoszewski W: Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbec-tomy model in rats. Brain Res Bull, 2003, 61, 159–164.
Nowak G, Szewczyk B: Mechanisms contributing to antidepressant zinc actions. Pol J Pharmacol, 2002, 54, 587–592.
Opoka W, Sowa-Kućma M, Stachowicz K, Ostachowicz B, Szlósarczyk M, Stypuła A, Młyniec K et al.: Early life time zinc supplementation protects zinc-deficient dietinduced alterations. Pharmacol Rep, 2010, 62, 1211–1217.
Paoletti P, Ascher P, Neyton J: High-affinity zinc inhibition of NMDA NR1-NR2 receptors. J Neurosci, 1997, 17, 5711–5725.
Partyka A, Jastrzębska-Więsek M, Szewczyk B, Stachowicz K, Sławińska A, Poleszak E, Doboszewska U et al.: Anxiolytic-like activity of zinc in rodent tests. Pharmacol Rep, 2011, 63, 1050–1055.
Porsolt RD, Bertin A, Jalfre M: Behavioural despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther, 1977, 229, 327–336.
Rosa AO, Lin J, Calixto JB, Santos ARS, Rodrigues ALS: Involvement of NMD A receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav Brain Res, 2003, 144, 87–93.
Schlegel-Zawadzka M, Zięba A, Dudek D, Krośniak M, Szymaczek M, Nowak G: Effect of depression and of antidepressant therapy on serum zinc levels. Trace Elements in Man and Animals, 2000, 10, 607–610.
Siwek M, Dudek D, Paul JA, Sowa-Kućma M, Zięba A, Popik P, Pilc A, Nowak G: Zinc supplementation augments efficacy of imipramine in treatment resistant patients: A double blind, placebo-controlled study. J Affect Disord, 2009, 118, 187–195.
Siwek M, Dudek D, Schlegel-Zawadzka M, Morawska A, Piekoszewski W, Opoka W, Zięba A et al.: Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord, 2010, 126, 447–452.
Skolnick P, Layer RT, Popik P, Nowak G, Paul IA, Trullas R: Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry, 1996, 29, 23–26.
Skolnick P, Popik P, Trullas R: Glutamate-based antidepressants: 20 years on. Trends Pharmacol Sci, 2009, 30, 563–569.
Sowa-Kućma M., Legutko B, Szewczyk B, Novak K, Znojek P, Poleszak E, Papp M et al.: Antidepressant-like activity of zinc: further behavioural and molecular evidence. J Neural Transm, 2008, 115, 1621–1628.
Suliman HB, Abdelrahim AI, Zakia AM, Shommein AM: Zinc deficiency in sheep: field cases. Trop Anim Health Prod, 1988, 20, 47–51.
Swaab DF, Bao AM, Lucassen PJ.: The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev, 2005, 4, 141–194.
Szewczyk B, Brański P, Wierońska JM, Palucha A, Pilc A, Nowak G: Interaction of zinc with antidepressants in the forced swimming test in mice. Pol J Pharmacol, 2002, 54, 681–685.
Szewczyk B, Poleszak E, Sowa-Kućma M, Siwek M, Dudek D, Ryszewska-Pokraśniewicz B, Radziwoń-Zaleska M et al.: Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacol Rep, 2008, 60, 588–599.
Szewczyk B, Poleszak E, Właź P, Wróbel A, Blicharska E, Cichy A, Dybała et al.: The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry, 2009, 33, 323–329.
Szymańska M, Budziszewska B, Jaworska-Feil L, Basta-Kaim A, Kubera M, Leśkiewicz M, Regulska M, Lasoń W: The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level ans FKBP51 concentration in prenatally stressed rats. Psychoneuroen-docrinology, 2009, 34, 822–832.
Takeda A, Hirate M, Tamano H, Oku N: Release of glutamate and GABA in the hippocampus under zinc deficiency. J Neurosci Res, 2003, 72, 537–542.
Takeda A, Itoh H, Tamano H, Oku N: Responsiveness to kainate in young rats after 2-week zinc deprivation. BioMetals, 2006, 19, 565–572.
Takeda A, Tamano H, Itoh H, Oku N: Attenuation of abnormal glutamate release in zinc deficiency by zinc and Yokukansan. Neurochem Int, 2008, 53, 230–235.
Takeda A, Tamano H, Kan F, Hanajima T, Yamada H, Oku N: Enhancement of social isolation-induced aggressive behavior of young mice by zinc deficiency. Life Sci, 2008, 82, 909–914.
Takeda A, Tamano H, Kan F, Itoh H, Oku N: Anxietylike behavior of young rats after 2-week zinc deprivation. Behav Brain Res, 2007, 177, 1–6.
Takeda A, Tamano H, Oku N: Involvement of unusual glutamate release in kainate-induced seizures in zinc-deficient adult rats. Epilepsy Res, 2005, 66, 137–143.
Takeda A, Tamano H: Insight into zinc signaling from dietary zinc deficiency. Brain Res Rev, 2009, 62, 33–44.
Takeda A, Tamano H: Zinc signaling through glucocorticoid and glutamate signaling in stressful circumstances. J Neurosci Res, 2010, 88, 3002–10.
Takeda A, Yamada K, Minami A, Nagano T, Oku N: Enhanced excitability of hipocampal mossy fibers and CA3 neurons under dietary zinc deficiency. Epilepsy Res, 2005, 63, 77–84.
Takeda A, Yamada K, Tamano H, Fuke S, Kawamura M, Oku N: Hippocampal calcium dyshomeostasis and long-term potentiation in 2-week zinc deficiency. Neurochem Int, 2008, 52, 241–246.
Tamano H, Kan F, Kawamura M, Oku N, Takeda A: Behavior in the forced swim test and neurochemical changes in the hippocampus in young rats after 2-week znic deprivation. Neurochem Int, 2009, 55, 536–541.
Trullas R, Skolnick P: Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol, 1990, 185, 1–10.
Valee BL: The function of metallothionein. Neurochem Int, 1995, 27, 23–33.
Van Den Eede F, Claes SJ: Mechanisms of depression: role of the HPAaxis. Drug Discov Today, 2004, 1, 413–418.
Watanabe M, Tamano H, Kikuchi T, Takeda A: Susceptibility to stress in young rats after 2-week zinc deprivation. Neurochem Int, 2010, 56, 410–416.